中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识

2021-12-30 中国抗癌协会泌尿男生殖系肿瘤专业委员会 泌尿外科杂志(电子版)

肾细胞癌是常见泌尿系统肿瘤,肾部分切除术(partial nephrectomy,PN) 是治疗肾癌的主要方法之一。

中文标题:

中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识

发布日期:

2021-12-30

简要介绍:

肾细胞癌是常见泌尿系统肿瘤,肾部分切除术(partial nephrectomy,PN) 是治疗肾癌的主要方法之一。中国抗癌协会泌尿男生殖系肿瘤专业委员会微创学组根据中国腹腔镜及机器人肾部分切除术的应用现状,结合国内外最新的理论与实践,经专家广泛讨论,制定中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识,以期给PN在肾肿瘤患者治疗中得到规范的应用提供理论依据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=517c91c0023a0248, title=中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识, enTitle=, guiderFrom=泌尿外科杂志(电子版), authorId=0, author=, summary=肾细胞癌是常见泌尿系统肿瘤,肾部分切除术(partial nephrectomy,PN) 是治疗肾癌的主要方法之一。, cover=https://img.medsci.cn/2022126/1643190344741_1608702.png, journalId=0, articlesId=null, associationId=1970, associationName=中国抗癌协会泌尿男生殖系肿瘤专业委员会, associationIntro=中国抗癌协会泌尿男生殖系肿瘤专业委员会, copyright=0, guiderPublishedTime=Thu Dec 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">肾细胞癌是常见泌尿系统肿瘤,肾部分切除术(partial nephrectomy,PN) 是治疗肾癌的主要方法之一。中国抗癌协会泌尿男生殖系肿瘤专业委员会微创学组根据中国腹腔镜及机器人肾部分切除术的应用现状,结合国内外最新的理论与实践,经专家广泛讨论,制定中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识,以期给PN在肾肿瘤患者治疗中得到规范的应用提供理论依据。</span></p>, tagList=[TagDto(tagId=218, tagName=肾肿瘤), TagDto(tagId=105203, tagName=肾部分切除术), TagDto(tagId=117298, tagName=泌尿生殖系肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4248, appHits=62, showAppHits=0, pcHits=470, showPcHits=4184, likes=0, shares=20, comments=3, approvalStatus=1, publishedTime=Thu Jan 27 15:44:00 CST 2022, publishedTimeString=2021-12-30, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Wed Jan 26 17:48:27 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Tue Jan 02 22:38:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识.pdf)])
中国肾肿瘤腹腔镜及机器人肾部分切除术专家共识.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188770, encodeId=74131188e7030, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1qAmSBl2XvLJnE5jjfeU70egBIwZ0EJGptMUBuI0z8W2JBBd5x0q5OevTNFRyuMyHbHicYkMhNEibuE8mlFseh6Q/132, createdBy=3ad52486240, createdName=底拉克波希, createdTime=Fri Jan 28 10:09:33 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188766, encodeId=a0ab1188e66d7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c406453452, createdName=ms7000000707438692, createdTime=Fri Jan 28 09:27:34 CST 2022, time=2022-01-28, status=1, ipAttribution=)]
    2022-01-28 底拉克波希

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188770, encodeId=74131188e7030, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/1qAmSBl2XvLJnE5jjfeU70egBIwZ0EJGptMUBuI0z8W2JBBd5x0q5OevTNFRyuMyHbHicYkMhNEibuE8mlFseh6Q/132, createdBy=3ad52486240, createdName=底拉克波希, createdTime=Fri Jan 28 10:09:33 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188766, encodeId=a0ab1188e66d7, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c406453452, createdName=ms7000000707438692, createdTime=Fri Jan 28 09:27:34 CST 2022, time=2022-01-28, status=1, ipAttribution=)]
    2022-01-28 ms7000000707438692

    不错

    0